1
|
Shane E: Clinical review 122: Parathyroid
carcinoma. J Clin Endocrinol Metab. 86:485–493. 2001. View Article : Google Scholar : PubMed/NCBI
|
2
|
Mori H, Okada Y, Arao T and Tanaka Y: Case
of parathyroid carcinoma with a highly aggressive clinical course.
J UOEH. 36:243–249. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Sadler C, Gow KW, Beierle EA, Doski JJ,
Langer M, Nuchtern JG, Vasudevan SA and Goldfarb M: Parathyroid
carcinoma in more than 1,000 patients: A population-level analysis.
Surgery. 156:1622–1630. 2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Asare EA, Sturgeon C, Winchester DJ, Liu
L, Palis B, Perrier ND, Evans DB, Winchester DP and Wang TS:
Parathyroid carcinoma: An update on treatment outcomes and
prognostic factors from the national cancer data base (NCDB). Ann
Surg Oncol. 22:3990–3995. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Marcocci C, Cetani F, Rubin MR, Silverberg
SJ, Pinchera A and Bilezikian JP: Parathyroid carcinoma. J Bone
Miner Res. 23:1869–1880. 2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Koea JB and Shaw JH: Parathyroid cancer:
Biology and management. Surg Oncol. 8:155–165. 1999. View Article : Google Scholar : PubMed/NCBI
|
7
|
Busaidy NL, Jimenez C, Habra MA, Schultz
PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM Jr, Evans DB, Gagel
RF, et al: Parathyroid carcinoma: A 22-year experience. Head Neck.
26:716–726. 2004. View Article : Google Scholar : PubMed/NCBI
|
8
|
Givi B and Shah JP: Parathyroid carcinoma.
Clin Oncol (R Coll Radiol). 22:498–507. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Mohebati A, Shaha A and Shah J:
Parathyroid carcinoma: Challenges in diagnosis and treatment.
Hematol Oncol Clin North Am. 26:1221–1238. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Schott M, Feldkamp J, Schattenberg D,
Krueger T, Dotzenrath C, Seissler J and Scherbaum WA: Induction of
cellular immunity in a parathyroid carcinoma treated withtumor
lysate-pulsed dendritic cells. Eur J Endocrinol. 142:300–306. 2000.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Bradwell AR and Harvey TC: Control of
hypercalcaemia of parathyroid carcinoma by immunisation. Lancet.
353:370–373. 1999. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang L, Han D, Chen W, Zhang S, Wang Z, Li
K, Gao Y, Zou S and Yang A: Non-functional parathyroid carcinoma: A
case report and review of the literature. Cancer Biol Ther.
16:1569–1576. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang J, Tong F, Zhong W and Li S: A case
report of anti-parathyroid hormone immunotherapy for parathyroid
carcinoma. J Diabetes Endocrinol. 2:36–40. 2011.
|
14
|
Siu WK, Law CY, Lam CW, Mak CM, Wong GW,
Ho AY, Ho KY, Loo KT, Chiu SC, Chow LT, et al: Novel nonsense CDC73
mutations in Chinese patients with parathyroid tumors. Fam Cancer.
10:695–699. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhao J, Hu Y, Liao Q, Niu Z, Xing X, Xia W
and Zhao Y: Gene identification of potential malignant parathyroid
tumors phenotype in Chinese population. Endocr J. 61:597–605. 2014.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Cao J, Chen C, Wang QL, Xu JJ and Ge MH:
Parathyroid carcinoma: A report of six cases with a brief review of
the literature. Oncol Lett. 10:3363–3368. 2015.PubMed/NCBI
|
17
|
McClenaghan F and Qureshi YA: Parathyroid
cancer. Gland Surg. 4:329–338. 2015.PubMed/NCBI
|
18
|
Harari A, Waring A, Fernandez-Ranvier G,
Hwang J, Suh I, Mitmaker E, Shen W, Gosnell J, Duh QY and Clark O:
Parathyroid carcinoma: A 43-year outcome and survival analysis. J
Clin Endocrinol Metab. 96:3679–3686. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Dąbrowska A, Tarach J and Zwolak A:
Primary hyperparathyroidism due to parathyroid cancer-a diagnostic
and management challenge. Endokrynol Pol. 66(150): 157–167.
2015.
|
20
|
Talat N and Schulte KM: Clinical
presentation, staging and long-term evolution of parathyroid
cancer. Ann Surg Oncol. 17:2156–2174. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Villar-del-Moral J, Jiménez-García A,
Salvador-Egea P, Martos-Martínez JM, Nuño-Vázquez-Garza JM,
Serradilla-Martín M, Gómez-Palacios A, Moreno-Llorente P,
Ortega-Serrano J and de la Quintana-Basarrate A: Prognostic factors
and staging systems in parathyroid cancer: A multicenter cohort
study. Surgery. 156:1132–1144. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Schwartz GG and Sahmoun AE: Ovarian cancer
incidence in the United States in relation to manufacturing
industry. Int J Gynecol Cancer. 24:247–251. 2014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Stevens RG: Working against our endogenous
circadian clock: Breast cancer and electric lighting in the modern
world. Mutat Res. 680:106–108. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Duan K and Mete Ö: Parathyroid Carcinoma:
Diagnosis and Clinical Implications. Turk Patoloji Derg. 31 Suppl
1:S80–S97. 2015.
|
25
|
Kassahun WT and Jonas S: Focus on
parathyroid carcinoma. Int J Surg. 9:13–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
26
|
DeLellis RA: Parathyroid carcinoma: An
overview. Adv Anat Pathol. 12:53–61. 2005. View Article : Google Scholar : PubMed/NCBI
|
27
|
Okamoto T, Iihara M, Obara T and Tsukada
T: Parathyroid carcinoma: Etiology, diagnosis, and treatment. World
J Surg. 33:2343–2354. 2009. View Article : Google Scholar : PubMed/NCBI
|
28
|
Gill AJ: Understanding the genetic basis
of parathyroid carcinoma. Endocr Pathol. 25:30–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Erovic BM, Harris L, Jamali M, Goldstein
DP, Irish JC, Asa SL and Mete O: Biomarkers of parathyroid
carcinoma. Endocr Pathol. 23:221–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
30
|
Kebebew E, Arici C, Duh QY and Clark OH:
Localization and reoperation results for persistent and recurrent
parathyroid carcinoma. Arch Surg. 136:878–885. 2001. View Article : Google Scholar : PubMed/NCBI
|
31
|
Munson ND, Foote RL, Northcutt RC, Tiegs
RD, Fitzpatrick LA, Grant CS, van Heerden JA, Thompson GB and Lloyd
RV: Parathyroid carcinoma: Is there a role for adjuvant radiation
therapy? Cancer. 98:2378–2384. 2003. View Article : Google Scholar : PubMed/NCBI
|
32
|
Owen RP, Silver CE, Pellitteri PK, Shaha
AR, Devaney KO, Werner JA, Rinaldo A and Ferlito A: Parathyroid
carcinoma: A review. Head Neck. 33:429–436. 2011.PubMed/NCBI
|
33
|
Obara T and Fujimoto Y: Diagnosis and
treatment of patients with parathyroid carcinoma: An update and
review. World J Surg. 15:738–744. 1991. View Article : Google Scholar : PubMed/NCBI
|
34
|
Qiu ZL, Wu CG, Zhu RS, Xue YL and Luo QY:
Unusual case of solitary functioning bone metastasis from a
‘parathyroid adenoma’: Imagiologic diagnosis and treatment with
percutaneous vertebroplasty-case report and literature review. J
Clin Endocrinol Metab. 98:3555–3561. 2013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Hundley JC, Albertson DA, Bradley RF and
Levine EA: Resection of pulmonary metastasis from parathyroid
carcinoma. Am Surg. 69:779–783. 2003.PubMed/NCBI
|
36
|
Iihara M, Okamoto T, Suzuki R, Kawamata A,
Nishikawa T, Kobayashi M and Obara T: Functional parathyroid
carcinoma: Long-term treatment outcome and risk factor analysis.
Surgery. 142:936–943.e1. 2007. View Article : Google Scholar : PubMed/NCBI
|